Radiation dose response in patients with favorable localized prostate cancer (Stage T1–T2, biopsy Gleason ≤ 6, and pretreatment prostate-specific antigen ≤ 10)
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 50 (3) , 621-625
- https://doi.org/10.1016/s0360-3016(01)01466-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Dose selection for prostate cancer patients based on dose comparison and dose response studiesInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostateUrology, 2000
- Declining Rates of Extracapsular Extension After Radical Prostatectomy: Evidence for Continued Stage MigrationJournal of Clinical Oncology, 1999
- 4 Preliminary results of a randomized dose-escalation study comparing 70 GY to 78 GY for the treatment of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- A Dose–Response Study for I-125 Prostate ImplantsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicityInternational Journal of Radiation Oncology*Biology*Physics, 1996